Gladstone Home GICD Home Blank GIVI Home GIND Home Blank
 
 
Supporting Gladstone
In the Press 2002-2004
New Clues To Understanding Huntington Disease: Inclusion Bodies May Protect Neurons
By Linda Carroll
Neurology Today, December, 2004
Using a robotic microscope to approximate time-lapse photography, researchers have found evidence that inclusion bodies, one of the hallmarks of Huntington’s disease, may actually protect neurons rather than damage them. In the new study, published in Nature, investigators found that... MORE
Follow That Cell
Today's Science on File, December, 2004
Clumps of mutant protein may not sound very appealing. But a new study by neurologist Steve Finkbeiner has shown that mutant protein clumps are actually a good thing––at least for people suffering from Huntington's disease. Moreover, the innovative equipment... MORE [PDF]
Research group plans expansion in new S.F. digs
By Daniel S. Levine
San Francisco Business Times, December 10, 2004
The J. David Gladstone Institutes will boost its research staff now that its gleaming new laboratories at Mission Bay are providing long-needed room to grow. The group of medical research institutes affiliated with UCSF plans to increase its ranks to 520 during the next five years... MORE
Gladstone Institutes Recognize Willie Brown
UCSF Today, December 9, 2004
At the December 6 dedication ceremony, Warner Greene, director of the Gladstone Institute of Virology and Immunology (GIVI), praised former San Francisco Mayor Willie Brown for “his strong hand in shaping the Gladstone Institutes”... MORE
Gladstone Scientist Offers Insight on Stem Cell ResearchGICD Logo
UCSF Today, December 9, 2004
Researchers and staff at the Gladstone Institutes welcomed the community to tour their new six-story building at Mission Bay on Monday, showcasing leading-edge scientific knowledge in coronary disease, HIV/AIDS and neurodegenerative diseases. Bruce Conklin, an investigator in the Gladstone Institute of Cardiovascular Disease... MORE
Gladstone Institutes Dedicate Mission Bay Research Building
UCSF Today, December 7, 2004
The J. David Gladstone Institutes, celebrating its 25th anniversary of scientific collaboration and achievement, dedicated its new six-story biomedical research building in Mission Bay on Monday. “This building marks a true milestone in Gladstone's history...” MORE
A KCBS-AM News Report about the dedication of the new Gladstone building at Mission Bay
Includes quote from Gladstone President Dr. Robert Mahley and former San Francisco Mayor Willie Brown

December 6, 2004

Download Audio Clip(1.2mb)

Biomed Doctors Move: New Mission Bay Site to House Research Facility
By Bonnie Eslinger
The San Francisco Examiner, December 6, 2004
Today, the University of California, San Francisco is celebrating its affiliation with a new biomedical research facility devoted to curing three of the world's most devastating diseases: heart disease, AIDS and Alzheimer's. Located in Mission Bay, the new six-story, 190,000-square-foot J. David Gladstone Institutes... MORE
Inclusion bodies acquitted: In Huntington's disease, clumps of mutant protein seem to be protective rather than harmful
By Maria W. Anderson
The Scientist, October 14, 2004
Inclusion bodies play a protective, not pathogenic, role in Huntington disease, according to this week's Nature cover story by Steven Finkbeiner, from the Gladstone Institute of Neurological Disease... MORE
Radical rethink of Huntington's disease
By Philip Cohen
New Scientist, October 13, 2004
Clumps of defective proteins, long implicated in killing off part of the brain in Huntington's disease, may actually be helping these neurons to survive. The discovery could redirect efforts to develop treatments... MORE
A KPIX-TV(CBS) News Report on Gladstone's move to Mission Bay includes a look inside the new building and quotes from Lennart Mucke and Warner Greene

October 10, 2004

Download Video Clip(2.7mb)
Requires Quicktime Player

$2.5 Million AIDS Grant Awarded Veteran Researcher to Study How
Body Can Suppress HIV

By Sabin Russell
San Francisco Chronicle, September 30, 2004
San Francisco AIDS researcher Dr. Joseph 'Mike' McCune was named Wednesday as one of nine winners of $2.5 million grants from the National Institutes of Health to carry out innovative medical research... MORE
Boost for Biotech in S.F. : Gladstone Institutes to Open Mission Bay Research Center
By Dan Levy
San Francisco Chronicle, September 10, 2004
There are no biotech companies at Mission Bay or anywhere else in San Francisco. The opening next month of the $72 million J. David Gladstone Institutes building, a center for biomedical research, might begin to change that... MORE
Second Chances: A Batch of New Drugs Could Be the Salvation for
Failing Regimens

By Bob Adams
HIV Plus, August, 2004
For HIV-positive people who have developed resistance to available antiretroviral medications, the pipeline of new anti-HIV drugs is something of a mixed blessing... MORE
Tweaking the Genes: Sweating the Small Stuff in Order to Stop HIV
By Bob Adams
HIV Plus, August, 2004
One of the most compelling areas of HIV treatment research combines thenewest, cutting-edge science with ancient immune system defenses that aremillions of years old. Called RNA interference... MORE
Robert Mahley TV Interview,Robert W. Mahley
June, 2004
Comcast Cable interview with Gladstone President Robert Mahley on cardiovascular issues, aired on CNN Local Edition throughout June, 2004...

View Quicktime Movie

$72M Biomed Facility Opening at Mission Bay
By Radhika Kaushik
Silicon Valley Biz Ink, June 18, 2004
Come October, San Francisco's Mission Bay will get a spanking new $72 million private biomedical research facility--the newest landmark in the city's evolving biotech corridor... MORE
Statin quo? The pros and cons of direct-to-consumer useGICD Logo
By Susan J. Landers
American Medical News, June 7, 2004
Millions of people worldwide use statins, and the medication's safety record is admirable, so why not allow sales of these lifesavers without a prescription?... MORE
Dr. Warner Greene

KGO-TV (ABC) News Report on AIDS Education Includes Quote from Dr. Warner C. Greene
April 19, 2004
GIVI Logo

.mov File
Quicktime
.wmv File
Windows Media Player

Deals of the Year: Best New Office/R&D Development Finalist
San Francisco Business Times, March 24, 2004
Gladstone Laboratories Building

– Download a pdf –
[2mb]

Immunologist Focuses on HIV
San Jose Mercury News, January 7, 2003
As the director of the Gladstone Institute of Virology and Immunology in San Francisco, Dr. Warner Greene works with his team of researchers to understand the most serious epidemic in the world, HIV... MORE
NIH Awards $8M To UCSF, Gladstone Institute
San Francisco Business Times, August 13, 2002
The National Institutes for Health has awarded the UCSF-Gladstone Institute of Virology and Immunology Center for AIDS Research (CFAR) $8 million for five years... MORE
Growth In HIV Resistant To Drugs
San Jose Mercury News, August 8, 2002
More than one-fifth of people recently infected in the United States and Canada with the virus that causes AIDS have strains that do not respond to some of the best anti-viral medications, according to a study in today’s New England Journal of
Medicine... MORE
Promising AIDS Drugs Raising Hopes
By Sabin Russell
San Francisco Chronicle, July 9, 2002
For the first time in years, American drug researchers have begun testing a new class of AIDS drugs on humans, the researchers said Monday at the 14th International AIDS Conference... MORE
Drug-Resistant HIV on Increase
By Randy Dotinga
HealthScout, July 8, 2002
In another sign that AIDS is evolving into a different kind of threat, researchers have found a growing number of newly infected people are immune to the two most powerful kinds of HIV drugs... MORE
InnovationsGIND Logo
Edited by Neil Gross
Business Week, June 24, 2002
Using conventional microscopes, Steven Finkbeiner was unable to fully monitor neurons ravaged by Huntington's disease. So the researcher at the Gladstone Institute of Neurological Disease invented a better scope... MORE

TOP


Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF